BMRA Stock Analysis: Buy, Sell, or Hold?

BMRA - BIOMERICA INC

IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
$2.38
-0.02 (-0.63%) ▼
HOLD
LOW Confidence
Protect Your BMRA Gains
Last Updated: January 30, 2026
Earnings: Jan 13, 2026 0d

Get Alerted When BMRA Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
📊 HOLD: BMRA shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.

In-depth Analysis How we analyze

Valuation Analysis: BMRA is currently trading at $2.38, which is considered oversold relative to its 30-day fair value range of $2.46 to $2.71.

Technical Outlook: Technically, BMRA is in a downtrend. The price is currently testing key support at $2.33. A bounce from this level would confirm strength, while a break below could signal further downside.

Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $13.00 (+443.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.

Quick Decision Summary

Current Position OVERSOLD
Fair Price Range $2.46 - $2.71
Company Quality Score 52/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 82.6%

Protect Your Profits

Holding BMRA? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

All Signals

  • BULLISH: Price oversold vs 30-day range
  • NEUTRAL: Mixed technical signals (40/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 443.9% below Wall St target ($13.00)
  • CAUTION: Recommendation downgraded due to -7.6% 5-day decline

Fair Price Analysis

30-Day Fair Range $2.46 - $2.71
Current vs Fair Value OVERSOLD

Support & Resistance Levels

Support Level $2.33
Resistance Level $2.74
Current Trend Downtrend

Fundamental Context

Wall Street Target $13.00 (+443.9%)
Revenue Growth (YoY) -23.6%
Profit Margin -74.8%
Last updated: January 31, 2026 1:06 PM ET
Data refreshes hourly during market hours. Next update: 2:06 PM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Top Rated Medical Devices Stocks

Top-rated stocks in Medical Devices by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
BSX
Boston Scientific Corp
STRONG BUY
34 analysts
$124 59 HOLD
DXCM
DexCom Inc
STRONG BUY
26 analysts
$85 65 BUY
ABT
Abbott Laboratories
BUY
28 analysts
$136 63 BUY
MDT
Medtronic PLC
BUY
32 analysts
$110 63 BUY
PODD
Insulet Corporation
STRONG BUY
23 analysts
$374 54 HOLD

Advanced BMRA Option Strategies

Professional options setups generated by AI based on today's BMRA price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for BMRA

BMRA Technical Chart BMRA Price Prediction BMRA Earnings Date BMRA Investment Advisor BMRA Fair Price Analyzer BMRA Options Advisor BMRA Options Chain BMRA Options Analysis BMRA Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals